Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jon Congleton Insider Profile
4 Followers
Jon Congleton, CEO, Director at Mineralys Therapeutics, Inc., holds 926.96K shares in Mineralys Therapeutics, Inc. (Ticker: MLYS).
Jon Congleton Mineralys Therapeutics, Inc. (MLYS)CEO, Director
Mineralys Therapeutics, Inc. (MLYS)
CEO, Director
Ranked #22,751 out of 97,944 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
+17.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Jon Congleton holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 27, 2023 - Today
Return:+81.60%
The most profitable trade made by Jon Congleton
Jon Congleton's Trading History
List of latest transactions for each holding click on a transaction to see Jon Congleton's performance on stock
You May Also Like
Jon Congleton insider profile FAQ
What is the percentage of profitable transactions made by Jon Congleton?
The percentage of profitable transactions made by Jon Congleton is 25%.
What is the average return per transaction made by Jon Congleton?
The average return per transaction made by Jon Congleton is 17.30%.
What stocks does Jon Congleton hold?
Jon Congleton holds: MLYS stocks.
What was Jon Congleton’s latest transaction?
Jon Congleton latest transaction was an Uninformative Sell of $591.68K.
What was Jon Congleton's most profitable transaction?
Jon Congleton’s most profitable transaction was an Informative Buy of MLYS stock on November 27, 2023. The return on the trade was 81.60%.
What is Jon Congleton's role in Mineralys Therapeutics, Inc.?
Jon Congleton's role in Mineralys Therapeutics, Inc. is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.